Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation

FEMS Microbiology Letters

Volumn 313, Issue 2, 2010, Pages 96-102

  Mowat, Eilidh ^a   Rajendran, Ranjith ^a   Williams, Craig ^b   McCulloch, Elaine ^b   Jones, Brian ^c   Lang, Sue ^d   Ramage, Gordon ^a  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Aspergillus fumigatus; Biofilm; LasIR; Pseudomonas aeruginosa

Indexed keywords

DECANOIC ACID; DECANOL; LAURYL ALCOHOL; MYRISTYL ALCOHOL; OCTANOIC ACID;

ASPERGILLUS FUMIGATUS; BACTERIAL CELL; BIOFILM; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; FUNGAL BIOMASS; FUNGUS GROWTH; GERMINATION; GROWTH INHIBITION; INTRACELLULAR SIGNALING; LETTER; NONHUMAN; ORGANISMAL INTERACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTIBIOSIS; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; BIOFILMS; GENE DELETION; GENES, BACTERIAL; HUMANS; PSEUDOMONAS AERUGINOSA; QUORUM SENSING;

ASPERGILLUS FUMIGATUS; PSEUDOMONAS AERUGINOSA;

EID: 78649498014     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2010.02130.x     Document Type: Letter

References (33)

1. Alem MA, Oteef MD, Flowers TH & Douglas LJ (2006) Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development. Eukaryot Cell 5: 1770-1779.
2. Amin R, Dupuis A, Aaron SD & Ratjen F (2010) The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 137: 171-176.
3. Askew DS (2008) Aspergillus fumigatus: virulence genes in a street-smart mold. Curr Opin Microbiol 11: 331-337.
4. Bakare N, Rickerts V, Bargon J & Just-Nubling G (2003) Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 46: 19-23.
5. Bandara HM, Lam OL, Watt RM, Jin LJ & Samaranayake LP (2010a) Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species. J Med Microbiol 59: 1225-1234.
6. Bandara HM, Yau JY, Watt RM, Jin LJ & Samaranayake LP (2010b) Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development. BMC Microbiol 10: 125.
7. Bergsson G, Arnfinnsson J, Steingrimsson O & Thormar H (2001) In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob Agents Ch 45: 3209-3212.
8. Chambers CE, Visser MB, Schwab U & Sokol PA (2005) Identification of N-acylhomoserine lactones in mucopurulent respiratory secretions from cystic fibrosis patients. FEMS Microbiol Lett 244: 297-304.
9. Chen H, Fujita M, Feng Q, Clardy J & Fink GR (2004) Tyrosol is a quorum-sensing molecule in Candida albicans. P Natl Acad Sci USA 101: 5048-5052.
10. Chitarra GS, Abee T, Rombouts FM, Posthumus MA & Dijksterhuis J (2004) Germination of Penicillium paneum conidia is regulated by 1-octen-3-ol, a volatile self-inhibitor. Appl Environ Microb 70: 2823-2829.
11. CLSI (2008) M38-A2 Reference Method for Broth Microdilution Antifungal Susceptibility Testing of Filamentous Fungi. CLSI Wayne, PA.
12. Davis-Hanna A, Piispanen AE, Stateva LI & Hogan DA (2008) Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol 67: 47-62.
13. Duan K, Dammel C, Stein J, Rabin H & Surette MG (2003) Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 50: 1477-1491.
14. Gilligan PH (1991) Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 4: 35-51.
15. Hogan DA & Kolter R (2002) Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296: 2229-2232.
16. Hogan DA, Vik A & Kolter R (2004) A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 54: 1212-1223.
17. Holcombe LJ, McAlester G, Munro CA et al. (2010) Pseudomonas aeruginosa secreted factors impair biofilm development in Candida albicans. Microbiology 156: 1476-1486.
18. Hornby JM, Jensen EC, Lisec AD et al. (2001) Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microb 67: 2982-2992.
19. Kerr JR (1994a) Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J Infection 28: 305-310.
20. Kerr JR (1994b) Suppression of fungal growth exhibited by Pseudomonas aeruginosa. J Clin Microbiol 32: 525-527.
21. Kerr JR, Taylor GW, Rutman A, Hoiby N, Cole PJ & Wilson R (1999) Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J Clin Pathol 52: 385-387.
22. Kubo I, Fujita T, Kubo A & Fujita K (2003) Modes of antifungal action of alkanols against Saccharomyces cerevisiae. Bioorg Med Chem 11: 1117-1122.
23. Lafon A, Han KH, Seo JA, Yu JH & D'Enfert C (2006) G-protein and cAMP-mediated signaling in aspergilli: a genomic perspective. Fungal Genet Biol 43: 490-502.
24. Lee H, Chang YC, Nardone G & Kwon-Chung KJ (2007) TUP1 disruption in Cryptococcus neoformans uncovers a peptide-mediated density-dependent growth phenomenon that mimics quorum sensing. Mol Microbiol 64: 591-601.
25. McAlester G, O'Gara F & Morrissey JP (2008) Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans. J Med Microbiol 57: 563-569.
26. Mowat E, Butcher J, Lang S, Williams C & Ramage G (2007) Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol 56: 1205-1212.
27. Shchepin R, Hornby JM, Burger E, Niessen T, Dussault P & Nickerson KW (2003) Quorum sensing in Candida albicans: probing farnesol's mode of action with 40 natural and synthetic farnesol analogs. Chem Biol 10: 743-750.
28. Shirtliff ME, Peters BM & Jabra-Rizk MA (2009) Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett. 299: 1-8.
29. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ & Greenberg EP (2000) Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407: 762-764.
30. Skov M, McKay K, Koch C & Cooper PJ (2005) Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy. Resp Med 99: 887-893.
31. Smith EE, Buckley DG, Wu Z et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. P Natl Acad Sci USA 103: 8487-8492.
32. Valenza G, Tappe D, Turnwald D, Frosch M, Konig C, Hebestreit H & Abele-Horn M (2008) Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros 7: 123-127.
33. Yadav V, Gupta J, Mandhan R, Chhillar AK, Dabur R, Singh DD & Sharma GL (2005) Investigations on anti-Aspergillus properties of bacterial products. Lett Appl Microbiol 41: 309-314.